Soluble Epoxide Hydrolase Inhibition and Insulin Resistance
Clinical trial NCT03486223 · COMPLETED
Trial details
- NCT number
- NCT03486223
- Sponsor
- Vanderbilt University Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-17
- Primary completion
- 2021-11-18
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.